Table 1 Characteristics of study responders and non-responders,* N = 1,500
From: Measuring patient perceptions about osteoporosis pharmacotherapy
Participant | Refused | Unable to reach | Ineligible | |||||
|---|---|---|---|---|---|---|---|---|
(N = 871) | (N = 171) | (N = 174)† | (N = 284) | |||||
n | (%)‡ | n | (%)‡ | n | (%)‡ | n | (%)‡ | |
Physician-diagnosed osteoporosis | 94 | (13.1) | 16 | (11.3) | 24 | (17.0) | 36 | (15.0) |
Fracture since age 40§ | 122 | (14.6) | 16 | (9.8) | 11 | (6.9) | 36 | (13.4) |
Etidronate use (ever) | 12 | (1.6) | 1 | (0.7) | 2 | (1.5) | 8 | (3.5) |
Hormone therapy | ||||||||
never | 552 | (68.9) | 113 | (73.4) | 108 | (72.5) | 187 | (73.6) |
now | 113 | (14.1) | 25 | (16.2) | 16 | (10.7) | 36 | (14.2) |
past | 136 | (17.0) | 16 | (10.4) | 25 | (16.8) | 31 | (12.2) |